openPR Logo
Press release

Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031

05-05-2025 11:06 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing marke

According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing marke

According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031.
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.

A more than 150-page report to understand trends, opportunity and forecast in MRD testing market to 2031 by technology (flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others), application (hematological malignancies, leukemia, lymphoma, solid tumors, and others), end use industry (hospitals and specialty clinics, diagnostic laboratories, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that Polymerase Chain Reaction (PCR) is expected to witness highest growth over the forecast period.

Within this market, hospitals and specialty clinics will remain the largest segment.

Download sample by clicking on MRD testing market

APAC is expected to witness highest growth over the forecast period.

Labcorp, F. Hoffmann-La Roche, Guardant Health, Sysmex Corporation, Neogenomics Laboratories, Adaptive Biotechnologies Corporation, Archerdx, Asuragen, Arup Laboratories are the major suppliers in the MRD testing market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1-972-636-5056

Explore Our Latest Publications

Hi-Fi System Market

Bearing for Mechanical and Electrical Product

Telecom Electronic Manufacturing Service Market

Timing Device Market

Visual Inspection Microscope Market

Construction Waste Crusher Market

Nonwovens for Construction Market

OSB Panel for Construction Market

Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=lucintel-forecasts-the-global-mrd-testing-market-to-reach-34-billion-by-2031]
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031 here

News-ID: 4000115 • Views:

More Releases from ABNewswire

Lucintel Forecasts the Global Cancer Testing Screening Market to Reach $161 billion by 2031
Lucintel Forecasts the Global Cancer Testing Screening Market to Reach $161 bill …
According to a market report by Lucintel, the future of the global cancer testing screening market looks promising with opportunities in the hospital, clinic, diagnostic center, and research institute applications. The global cancer testing screening market is expected to reach an estimated $161 billion by 2031 from $91.7 billion in 2024, at a CAGR of 7.9% from 2025 to 2031. According to a market report by Lucintel, the future of the
Lucintel Forecasts the Global Patient-Centric Health Care App Market is expected to grow with a CAGR of 17.6% from 2025 to 2031
Lucintel Forecasts the Global Patient-Centric Health Care App Market is expected …
According to a market report by Lucintel, the future of the global patient-centric health care app market looks promising with opportunities in the hospital, clinic and home use markets. The global patient-centric health care app market is expected to grow with a CAGR of 17.6% from 2025 to 2031 According to a market report by Lucintel, the future of the global patient-centric health care app market looks promising with opportunities in
Lucintel Forecasts Smart Port Market to Reach $13.6 billion by 2031
Lucintel Forecasts Smart Port Market to Reach $13.6 billion by 2031
According to the recent study the smart port market is projected to reach an estimated $13.6 billion by 2031 from $3.3 billion in 2024, at a CAGR of 22.3% from 2024 to 2030. Growth in this market is primarily driven by increasing government initiatives for smart port, growing maritime transportation, and rising adoption of IoT technology. According to the recent study the smart port market is projected to reach an estimated
U.S. Data Center Construction Market Investment to Reach $112.33 Billion by 2030 - Arizton
U.S. Data Center Construction Market Investment to Reach $112.33 Billion by 2030 …
According to Arizton's latest research report, U.S. data center construction market [https://www.arizton.com/market-reports/united-states-data-center-construction-market-2024] is growing at a CAGR of 15.15% during 2024-2030. To Know More, Click: [https://www.arizton.com/market-reports/united-states-data-center-construction-market-2024] Report Summary Market Size - Investment (2030): $112.33 Billion Market Size - Investment (2024): $48.18 Billion CAGR by Investment (2024-2030): 15.15% Market Size - Area (2030): 35.37 Million Sq. Ft. Power Capacity (2030): 8,874 MW Historic Year: 2021-2023 Base Year: 2024 Forecast Year: 2025-2030 Regional Analysis: US (Southeastern, Midwestern, Southwestern, Western, and Northeastern) Market Overview The U.S.

All 5 Releases


More Releases for MRD

MRD (Minimal Residual Disease) Testing Market to Witness Huge Growth by Key Play …
According to Market Study Report, MRD (Minimal Residual Disease) Testing Market provides a comprehensive analysis of the MRD (Minimal Residual Disease) Testing Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5228316 The report provides a comprehensive analysis of company profiles listed below: -
MRD (Minimal Residual Disease) Testing Market CAGR, Volume and Value 2021-2027 | …
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the MRD (Minimal Residual Disease) Testing industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The MRD (Minimal Residual Disease) Testing market survey report has been prepared by conducting market research in a systematic manner. Moreover, the MRD (Minimal
Major Depressive Disorder Market Is Expand To Touch Perspective Value By 2024 Co …
The research study covers the current scenario and growth prospects of the Major Depressive Disorder market (2020-2024) according to the analysis . This study includes a extensive analysis of the key segments of the industry and also the regional analysis that are taken place throughout the country. Global Major Depressive Disorder Market Overview: The report also reveals in-depth details of shifting market dynamics, pricing structures, trends, restraints, limitations, demand-supply variations, growth-boosting
COVID-19 UV Light Solution
New York-based MRD Lighting, a major vendor to the international cruise industry, is developing ultraviolet lighting prototypes to combat airborne and surface-transmitted viruses aboard ships. The company, which has consistently innovated in providing a wide array of solutions to cruise lines, is working with subject matter experts in the radiological and epidemiology arenas to provide rapid-response capabilities as the Coronavirus increasingly impacts the cruise industry. "We have been expanding our capabilities and
Can quantitative chimerism monitoring serve as surrogate marker to predict clini …
A promising method indicates success Allogeneic stem cell transplantation (HSCT) is an effective therapy for hematopoietic disorders such as Acute Myeloid Leukemia (AML) or the Myelodysplastic Syndrome (MDS). However, imminent relapse remains a serious problem. Routinely, monitoring of minimal residual disease (MRD) by diseases-specific markers such as FLT3, NPM1, BCR-ABL, AML-ETO and others is performed to signify threatening relapse as early as possible. However, a high number of patients lack
Power Requirements a Vital Consideration for International Major Events
Saint Petersburg, Russia: Aggreko, the world leader in the provision of temporary power and temperature control services will be demonstrating the “efficiency for every stage” concept at SportAccord Convention 2013, as it continues its partnership with the most important event on the international sports business calendar. Aggreko will be exhibiting at the Lenexpo Exhibition Centre in Saint Petersburg, presenting this new concept to senior executives and key decision makers responsible